Chinese General Practice ›› 2022, Vol. 25 ›› Issue (27): 3358-3364.DOI: 10.12114/j.issn.1007-9572.2022.0263
Special Issue: 呼吸疾病文章合辑; 老年问题最新文章合辑
• Article • Previous Articles Next Articles
Received:
2022-03-12
Revised:
2022-04-20
Published:
2022-09-20
Online:
2022-06-23
Contact:
Muyun ZHU
About author:
通讯作者:
朱慕云
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0263
组别 | 例数 | 性别〔n(%)〕 | 年龄( | BMI( | 吸烟量( | PMcsa( | PMI( | |
---|---|---|---|---|---|---|---|---|
男 | 女 | |||||||
GOLDⅠ级组 | 47 | 37(78.7) | 10(21.3) | 69.0±5.9 | 24.0±3.1 | 24.37±12.68 | 23.64±8.30 | 8.48±2.71 |
GOLDⅡ级组 | 88 | 71(80.7) | 17(19.3) | 71.1±7.3 | 23.5±3.4 | 25.35±13.69 | 19.94±5.74b | 7.21±1.97b |
GOLDⅢ级组 | 84 | 70(83.3) | 14(16.7) | 72.3±7.9 | 22.8±3.3b | 25.36±13.83 | 16.78±5.00bc | 6.04±1.70bc |
GOLDⅣ级组 | 51 | 42(82.3) | 9(17.7) | 71.0±6.6 | 21.4±3.0bcd | 26.40±15.69 | 14.19±4.60bcd | 5.22±1.61bcd |
F(χ2)值 | 0.491a | 2.292 | 6.587 | 0.056 | 25.902 | 27.776 | ||
P值 | 0.921 | 0.078 | 0.001 | 0.982 | <0.001 | <0.001 | ||
组别 | PMD( | FEV1%pred( | FEV1( | FVC( | 肺体积( | 右肺LAA%( | 左肺LAA%( | 总肺LAA%( |
GOLDⅠ级组 | 36.49±12.42 | 87.23±7.14 | 2.00±0.46 | 2.90±0.62 | 5.18±1.07 | 13.21±6.65 | 13.81±6.95 | 13.54±6.77 |
GOLDⅡ级组 | 35.01±10.40 | 61.14±7.89b | 1.55±0.38b | 2.49±0.66b | 5.31±1.36 | 15.37±8.93b | 15.32±8.37b | 15.35±8.59b |
GOLDⅢ级组 | 32.97±11.46b | 41.17±6.05bc | 1.19±0.36bc | 2.22±0.65bc | 5.48±1.40 | 18.66±7.77bc | 18.86±8.66bc | 18.89±7.90bc |
GOLDⅣ级组 | 30.99±8.84bcd | 25.86±4.45bcd | 0.91±0.43bcd | 1.82±0.69bcd | 5.36±0.99 | 25.23±8.42bcd | 24.24±7.30bcd | 24.88±7.85bcd |
F(χ2)值 | 2.673 | 851.052 | 73.969 | 24.910 | 0.621 | 22.600 | 18.319 | 21.649 |
P值 | 0.048 | <0.001 | <0.001 | <0.001 | 0.602 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of clinical data of patients with different grades of COPD
组别 | 例数 | 性别〔n(%)〕 | 年龄( | BMI( | 吸烟量( | PMcsa( | PMI( | |
---|---|---|---|---|---|---|---|---|
男 | 女 | |||||||
GOLDⅠ级组 | 47 | 37(78.7) | 10(21.3) | 69.0±5.9 | 24.0±3.1 | 24.37±12.68 | 23.64±8.30 | 8.48±2.71 |
GOLDⅡ级组 | 88 | 71(80.7) | 17(19.3) | 71.1±7.3 | 23.5±3.4 | 25.35±13.69 | 19.94±5.74b | 7.21±1.97b |
GOLDⅢ级组 | 84 | 70(83.3) | 14(16.7) | 72.3±7.9 | 22.8±3.3b | 25.36±13.83 | 16.78±5.00bc | 6.04±1.70bc |
GOLDⅣ级组 | 51 | 42(82.3) | 9(17.7) | 71.0±6.6 | 21.4±3.0bcd | 26.40±15.69 | 14.19±4.60bcd | 5.22±1.61bcd |
F(χ2)值 | 0.491a | 2.292 | 6.587 | 0.056 | 25.902 | 27.776 | ||
P值 | 0.921 | 0.078 | 0.001 | 0.982 | <0.001 | <0.001 | ||
组别 | PMD( | FEV1%pred( | FEV1( | FVC( | 肺体积( | 右肺LAA%( | 左肺LAA%( | 总肺LAA%( |
GOLDⅠ级组 | 36.49±12.42 | 87.23±7.14 | 2.00±0.46 | 2.90±0.62 | 5.18±1.07 | 13.21±6.65 | 13.81±6.95 | 13.54±6.77 |
GOLDⅡ级组 | 35.01±10.40 | 61.14±7.89b | 1.55±0.38b | 2.49±0.66b | 5.31±1.36 | 15.37±8.93b | 15.32±8.37b | 15.35±8.59b |
GOLDⅢ级组 | 32.97±11.46b | 41.17±6.05bc | 1.19±0.36bc | 2.22±0.65bc | 5.48±1.40 | 18.66±7.77bc | 18.86±8.66bc | 18.89±7.90bc |
GOLDⅣ级组 | 30.99±8.84bcd | 25.86±4.45bcd | 0.91±0.43bcd | 1.82±0.69bcd | 5.36±0.99 | 25.23±8.42bcd | 24.24±7.30bcd | 24.88±7.85bcd |
F(χ2)值 | 2.673 | 851.052 | 73.969 | 24.910 | 0.621 | 22.600 | 18.319 | 21.649 |
P值 | 0.048 | <0.001 | <0.001 | <0.001 | 0.602 | <0.001 | <0.001 | <0.001 |
项目 | FEV1%pred | FEV1 | FVC | |||
---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | |
PMcsa | 0.589 | <0.01 | 0.326 | <0.01 | 0.419 | <0.01 |
PMI | 0.623 | <0.01 | 0.411 | <0.01 | 0.410 | <0.01 |
PMD | 0.232 | <0.01 | 0.227 | <0.01 | 0.281 | <0.01 |
右肺LAA% | -0.525 | <0.01 | -0.270 | <0.01 | -0.091 | 0.13 |
左肺LAA% | -0.501 | <0.01 | -0.251 | <0.01 | -0.044 | 0.47 |
总肺LAA% | -0.538 | <0.01 | -0.273 | <0.01 | -0.064 | 0.29 |
肺体积 | -0.061 | 0.31 | 0.014 | 0.81 | 0.149 | 0.01 |
Table 2 Correlation analysis of pectoralis major muscle parameters,low attenuation area ratio and lung function
项目 | FEV1%pred | FEV1 | FVC | |||
---|---|---|---|---|---|---|
r值 | P值 | r值 | P值 | r值 | P值 | |
PMcsa | 0.589 | <0.01 | 0.326 | <0.01 | 0.419 | <0.01 |
PMI | 0.623 | <0.01 | 0.411 | <0.01 | 0.410 | <0.01 |
PMD | 0.232 | <0.01 | 0.227 | <0.01 | 0.281 | <0.01 |
右肺LAA% | -0.525 | <0.01 | -0.270 | <0.01 | -0.091 | 0.13 |
左肺LAA% | -0.501 | <0.01 | -0.251 | <0.01 | -0.044 | 0.47 |
总肺LAA% | -0.538 | <0.01 | -0.273 | <0.01 | -0.064 | 0.29 |
肺体积 | -0.061 | 0.31 | 0.014 | 0.81 | 0.149 | 0.01 |
变量 | 系数(95%CI) | SE | t值 | P值 |
---|---|---|---|---|
常量 | 35.519(25.852,45.186) | 4.910 | 7.234 | <0.001 |
性别 | 10.215(4.064,16.365) | 3.124 | 3.270 | 0.001 |
总肺LAA% | -0.698(-0.950,-0.446) | 0.128 | -5.456 | <0.001 |
PMcsa | 1.506(1.154,1.857) | 0.178 | 8.436 | <0.001 |
Table 3 Multiple linear regression analysis of PMcsa,LAA% and lung function indicators in COPD patiens
变量 | 系数(95%CI) | SE | t值 | P值 |
---|---|---|---|---|
常量 | 35.519(25.852,45.186) | 4.910 | 7.234 | <0.001 |
性别 | 10.215(4.064,16.365) | 3.124 | 3.270 | 0.001 |
总肺LAA% | -0.698(-0.950,-0.446) | 0.128 | -5.456 | <0.001 |
PMcsa | 1.506(1.154,1.857) | 0.178 | 8.436 | <0.001 |
项目 | 男 | 女 | ||||||
---|---|---|---|---|---|---|---|---|
AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
右肺LAA% | 0.832(0.769,0.885) | 15.25 | 0.841 | 0.727 | 0.844(0.735,0.953) | 14.62 | 0.792 | 0.801 |
左肺LAA% | 0.827(0.777,0.887) | 15.85 | 0.833 | 0.715 | 0.801(0.669,0.920) | 13.85 | 0.625 | 0.754 |
总肺LAA% | 0.834(0.778,0.891) | 16.71 | 0.807 | 0.784 | 0.845(0.737,0.954) | 13.61 | 0.792 | 0.753 |
PMcsa | 0.809(0.742,0.858) | 19.05 | 0.667 | 0.881 | 0.839(0.726,0.953) | 13.96 | 0.769 | 0.871 |
Table 4 Efficacy of PMcsa and low attenuation area ratio in predicting FEV1% pred<50% in patients of different genders
项目 | 男 | 女 | ||||||
---|---|---|---|---|---|---|---|---|
AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
右肺LAA% | 0.832(0.769,0.885) | 15.25 | 0.841 | 0.727 | 0.844(0.735,0.953) | 14.62 | 0.792 | 0.801 |
左肺LAA% | 0.827(0.777,0.887) | 15.85 | 0.833 | 0.715 | 0.801(0.669,0.920) | 13.85 | 0.625 | 0.754 |
总肺LAA% | 0.834(0.778,0.891) | 16.71 | 0.807 | 0.784 | 0.845(0.737,0.954) | 13.61 | 0.792 | 0.753 |
PMcsa | 0.809(0.742,0.858) | 19.05 | 0.667 | 0.881 | 0.839(0.726,0.953) | 13.96 | 0.769 | 0.871 |
项目 | 男 | 女 | ||||||
---|---|---|---|---|---|---|---|---|
AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
右肺LAA% | 0.830(0.753,0.898) | 9.85 | 0.861 | 0.647 | 0.805(0.657,0.933) | 7.25 | 0.897 | 0.641 |
左肺LAA% | 0.815(0.738,0.885) | 9.80 | 0.873 | 0.638 | 0.817(0.697,0.938) | 6.98 | 0.825 | 0.653 |
总肺LAA% | 0.831(0.760,0.899) | 9.28 | 0.887 | 0.643 | 0.807(0.675,0.939) | 7.23 | 0.882 | 0.624 |
PMcsa | 0.844(0.784,0.907) | 24.82 | 0.667 | 0.881 | 0.846(0.714,0.977) | 15.03 | 0.755 | 0.811 |
Table 5 Efficacy of PMcsa and low attenuation area ratio in predicting FEV1% pred<80% in patients of different genders
项目 | 男 | 女 | ||||||
---|---|---|---|---|---|---|---|---|
AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | AUC(95%CI) | 截断值(%) | 灵敏度 | 特异度 | |
右肺LAA% | 0.830(0.753,0.898) | 9.85 | 0.861 | 0.647 | 0.805(0.657,0.933) | 7.25 | 0.897 | 0.641 |
左肺LAA% | 0.815(0.738,0.885) | 9.80 | 0.873 | 0.638 | 0.817(0.697,0.938) | 6.98 | 0.825 | 0.653 |
总肺LAA% | 0.831(0.760,0.899) | 9.28 | 0.887 | 0.643 | 0.807(0.675,0.939) | 7.23 | 0.882 | 0.624 |
PMcsa | 0.844(0.784,0.907) | 24.82 | 0.667 | 0.881 | 0.846(0.714,0.977) | 15.03 | 0.755 | 0.811 |
[1] |
陈亚红. 2019年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版),2019,11(1):1-14. DOI:10.12037/YXQY.2019.01-01.
|
[2] |
|
[3] |
|
[4] |
刘金良,庞军,李晓冬,等. 慢性阻塞性肺疾病患者胸部定量CT参数与肺功能检测指标相关性分析[J]. 临床肺科杂志,2020,25(12):1831-1835. DOI:10.3969/j.issn.1009-6663.2020.12.012.
|
[5] |
|
[6] |
沈宁,贺蓓. 肺功能检查在慢性阻塞性肺疾病诊断及治疗中的临床意义[J]. 中华结核和呼吸杂志,2019,42(1):73-78. DOI:10.3760/cma.j.issn.1001-0939.2019.01.023.
|
[7] |
文富强,申永春,陈磊. 肺功能检查在中国慢性阻塞性肺疾病患者中的实践:挑战与对策[J]. 中华结核和呼吸杂志,2017,40(12):891-893. DOI:10.3760/cma.j.issn.1001-0939.2017.12.004.
|
[8] |
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 常规肺功能检查基层指南(2018年)[J]. 中华全科医师杂志,2019,18(6):511-518. DOI:10.3760/cma.j.issn.1671-7368.2019.06.003.
|
[9] |
|
[10] |
李艳,高俊刚,郭佑民,等. 支气管炎型和肺气肿型COPD患者CT定量指标及肺功能的纵向变化研究[J]. 临床放射学杂志,2020,39(6):1104-1107. DOI:10.13437/j.cnki.jcr.2020.06.017.
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
任涛. 基于MSCT慢性阻塞性肺疾病定量参数对肺功能指标的预测价值[D]. 银川:宁夏医科大学,2021.
|
[18] |
董中兴,沈慧君,龚李艳,等. 肺叶低密度区容积百分比对慢性阻塞性肺病患者肺功能受损程度的评估作用[J]. 内科急危重症杂志,2017,23(5):365-367,374. DOI:10.11768/nkjwzzzz20170504.
|
[19] |
兰长青,王洁,黄梅萍,等. CT肺气肿指数及空间分布对慢性阻塞性肺疾病肺损伤的评估价值[J]. 中国临床医学影像杂志,2021,32(5):320-325. DOI:10.12117/jccmi.2021.05.004.
|
[20] |
|
[21] |
|
[1] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[2] | LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778. |
[3] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[4] | YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263. |
[5] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[6] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[7] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[8] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[9] | YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004. |
[10] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[12] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
[13] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[14] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[15] | WEI Xiaoxia, CHEN Nuo, WANG Juanjuan, ZHU Jingfen. The Effects of Depression and Anxiety on Smoking Behavior among Vocational School Students [J]. Chinese General Practice, 2025, 28(22): 2826-2832. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||